Characteristics of Glycemic Control and Long-Term Complications in Patients with Young-Onset Type 2 Diabetes (Endocrinol Metab 2022;37:641-51, Han-sang Baek et al.).
作者信息
Baek Han-Sang, Park Ji-Yeon, Yu Jin, Lee Joonyub, Yang Yeoree, Ha Jeonghoon, Lee Seung Hwan, Cho Jae Hyoung, Lim Dong-Jun, Kim Hun-Sung
机构信息
Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
出版信息
Endocrinol Metab (Seoul). 2022 Dec;37(6):945-946. doi: 10.3803/EnM.2022.602. Epub 2022 Dec 2.
Abstract
摘要
相似文献
1
Characteristics of Glycemic Control and Long-Term Complications in Patients with Young-Onset Type 2 Diabetes (Endocrinol Metab 2022;37:641-51, Han-sang Baek et al.).青年起病的2型糖尿病患者血糖控制特征及长期并发症（《内分泌与代谢》2022年；37:641 - 51，韩相白等）
Endocrinol Metab (Seoul). 2022 Dec;37(6):945-946. doi: 10.3803/EnM.2022.602. Epub 2022 Dec 2.
2
Characteristics of Glycemic Control and Long-Term Complications in Patients with Young-Onset Type 2 Diabetes (Endocrinol Metab 2022;37:641-51, Han-sang Baek et al.).青年起病的2型糖尿病患者血糖控制特征及长期并发症（《内分泌与代谢》2022年；37卷：641 - 51页，韩相白克等人）
Endocrinol Metab (Seoul). 2022 Dec;37(6):943-944. doi: 10.3803/EnM.2022.1601. Epub 2022 Nov 23.
3
Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78).达到目标糖化血红蛋白的时间与新诊断2型糖尿病患者的长期持久血糖控制及糖尿病并发症风险相关：一项6年观察性研究（《糖尿病与代谢杂志》2021年；45:368 - 78）
Diabetes Metab J. 2021 Jul;45(4):613-614. doi: 10.4093/dmj.2021.0129. Epub 2021 Jul 30.
4
Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78).达到目标糖化血红蛋白的时间与新诊断2型糖尿病患者的长期持久血糖控制及糖尿病并发症风险相关：一项6年观察性研究（《糖尿病与代谢杂志》2021年；45:368 - 78）
Diabetes Metab J. 2021 Jul;45(4):617-618. doi: 10.4093/dmj.2021.0152. Epub 2021 Jul 30.
5
Response: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes ( 2019; 34:382-9, Han Na Jang et al.).回应：2型糖尿病成人患者从基础胰岛素转换为每日一次德谷胰岛素/门冬胰岛素后血糖得到良好控制（2019年；34:382 - 389，Han Na Jang等人）
Endocrinol Metab (Seoul). 2020 Mar;35(1):194-195. doi: 10.3803/EnM.2020.35.1.194.
6
Letter: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes ( 2019; 34:382-9, Han Na Jang et al.).信函：成人 2 型糖尿病患者从基础胰岛素转换为每日一次德谷胰岛素/门冬胰岛素后血糖控制良好（2019 年；34：382 - 389，Han Na Jang 等人）
Endocrinol Metab (Seoul). 2020 Mar;35(1):192-193. doi: 10.3803/EnM.2020.35.1.192.
7
Characteristics of Glycemic Control and Long-Term Complications in Patients with Young-Onset Type 2 Diabetes.年轻起病 2 型糖尿病患者的血糖控制特点及长期并发症。
Endocrinol Metab (Seoul). 2022 Aug;37(4):641-651. doi: 10.3803/EnM.2022.1501. Epub 2022 Aug 29.
8
Correspondence: Short- and long-term prognosis of glycemic control in COVID-19 patients with type 2 diabetes.通信：2型糖尿病COVID-19患者血糖控制的短期和长期预后
QJM. 2023 May 27;116(5):401-402. doi: 10.1093/qjmed/hcac138.
9
Association of Protein Z with Prediabetes and Type 2 Diabetes (Endocrinol Metab 2021;36:637-46, Yun-Ui Bae et al.).蛋白Z与糖尿病前期和2型糖尿病的关联（《内分泌与代谢》2021年；36:637 - 46，Bae Yun - Ui等人）
Endocrinol Metab (Seoul). 2021 Oct;36(5):1149-1150. doi: 10.3803/EnM.2021.502. Epub 2021 Sep 16.
10
Association of Protein Z with Prediabetes and Type 2 Diabetes (Endocrinol Metab 2021;36:637-46, Yun-Ui Bae et al.).蛋白质Z与糖尿病前期和2型糖尿病的关联（《内分泌与代谢》2021年；36:637 - 46，Bae Yun - Ui等人）
Endocrinol Metab (Seoul). 2021 Oct;36(5):1147-1148. doi: 10.3803/EnM.2021.1204. Epub 2021 Aug 25.
本文引用的文献
1
Characteristics of Glycemic Control and Long-Term Complications in Patients with Young-Onset Type 2 Diabetes.年轻起病 2 型糖尿病患者的血糖控制特点及长期并发症。
Endocrinol Metab (Seoul). 2022 Aug;37(4):641-651. doi: 10.3803/EnM.2022.1501. Epub 2022 Aug 29.
2
Medication adherence in young adults with youth-onset type 2 diabetes: iCount, an observational study.青少年 2 型糖尿病患者的药物依从性：iCount，一项观察性研究。
Diabetes Res Clin Pract. 2022 Feb;184:109216. doi: 10.1016/j.diabres.2022.109216. Epub 2022 Jan 24.
3
Young-onset type 2 diabetes in South Korea: a review of the current status and unmet need.韩国的青年 2 型糖尿病：现状及未满足需求的综述。
Korean J Intern Med. 2021 Sep;36(5):1049-1058. doi: 10.3904/kjim.2021.379. Epub 2021 Sep 1.
4
Healthcare Providers' Perception of Healthcare System Factors Associated with Poor Glycemic Control among Type 2 Diabetes Patients in Fiji.斐济医疗服务提供者对2型糖尿病患者血糖控制不佳相关医疗系统因素的认知
Rev Diabet Stud. 2019;15:49-57. doi: 10.1900/RDS.2019.15.49. Epub 2019 Aug 4.
5
Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort.亚洲年轻起病 2 型糖尿病的代谢特征和治疗差距（JADE 项目）：一项前瞻性队列的横断面研究。
Lancet Diabetes Endocrinol. 2014 Dec;2(12):935-43. doi: 10.1016/S2213-8587(14)70137-8. Epub 2014 Jul 28.
Zotero 插件